Keywords: CEST & MT, Tumor, APTw Imaging, Perfusion, Metastases, Radionecrosis, Tumor ProgressionThe distinction between radionecrosis and tumor recurrence is a common diagnostic dilemma, as current advanced multiparametric MRI protocols lack on accuracy. Fluid-Suppressed Amide Proton Transfer weighted (APTw) imaging has strong potentials in brain tumor post-therapeutic assessment. In this study we compare at 3T the diagnostic accuracy of Fluid Suppressed APTw with the most used advanced technique, i.e. the Leakage-Corrected relative Cerebral Blood Volume imaging obtained by DSC perfusion in 22 pre-irradiated metastases. Results show that Fluid-Suppressed APTw metrics can clearly make a distinction between these two pathologies, in contrast to Leakage-Corrected rCBV contrast.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords